Evandra Strazza Rodrigues

Dr. Evandra Strazza Rodrigues

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Clinical Immunology
Verified
Journal Article
Closed access
LALucas Coelho Marlière Arruda
Lucas Coelho Marlière Arruda
JAJúlia T.C. de Azevedo
Júlia T.C. de Azevedo
Gislane Lelis Vilela de OliveiraGislane Lelis Vilela de Oliveira
Gislane Lelis Vilela de Oliveira
GSGabriela T. Scortegagna
Gabriela T. Scortegagna
EREvandra Strazza Rodrigues
Evandra Strazza Rodrigues
Kelen Cristina Ribeiro MalmegrimKelen Cristina Ribeiro Malmegrim
Kelen Cristina Ribeiro Malmegrim

20 December 2006 in Transfusion
Verified
Journal Article
Closed access
PDF file
DCDimas Tadeu Covas
Dimas Tadeu Covas
FOFabíola Singaretti De Oliveira
Fabíola Singaretti De Oliveira
EREvandra Strazza Rodrigues
Evandra Strazza Rodrigues
KAKiyoko Abe‐Sandes
Kiyoko Abe‐Sandes
WJWilson Araujo Silva Jr
Wilson Araujo Silva Jr
AFAparecida Maria Fontes
Aparecida Maria Fontes

1 June 2012 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
MPMariana Tomazini Pinto
Mariana Tomazini Pinto
EREvandra Strazza Rodrigues
Evandra Strazza Rodrigues
TMTathiane Maistro Malta
Tathiane Maistro Malta
RARochele Azevedo
Rochele Azevedo
OTOsvaldo Massaiti Takayanagui
Osvaldo Massaiti Takayanagui
SKSimone Kashima
Simone Kashima
The seroprevalence and geographic distribution of HTLV-1/2 among blood donors are extremely important to transfusion services. We evaluated the seroprevalence of HTLV-1/2 infection among first-time blood donor candidates in Ribeirão Preto city and region. From January 2000 to December 2010, 1,038,489 blood donations were obtained and 301,470 were first-time blood donations. All samples were screened with serological tests for HTLV-1/2 using enzyme immunoassay (EIA). In addition, the frequency of coinfection with hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), Chagas disease (CD) and syphilis was also determined. In-house PCR was used as confirmatory test for HTLV-1/2. A total of 296 (0.1%) first-time donors were serologically reactive for HTLV-1/2. Confirmatory PCR of 63 samples showed that 28 were HTLV-1 positive, 13 HTLV-2 positive, 19 negative and three indeterminate. Regarding HTLV coinfection rates, the most prevalent was with HBV (51.3%) and HCV (35.9%), but coinfection with HIV, CD and syphilis was also detected. The real number of HTLV-infected individual and coinfection rate in the population is underestimated and epidemiological studies like ours are very informative.

10 December 2021 in Viruses
Verified
Journal Article
Open access
PDF file
JLJéssika Cristina Chagas Lesbon
Jéssika Cristina Chagas Lesbon
MPMirele Daiana Poleti
Mirele Daiana Poleti
EMElisangela Chicaroni de Mattos
Elisangela Chicaroni de Mattos
JPJose Patane
Jose Patane
LCLuan Gaspar Clemente
Luan Gaspar Clemente
HFHeidge Fukumasu
Heidge Fukumasu
The current COVID-19 pandemic demands massive testing by Real-time RT-PCR (Reverse Transcription Polymerase Chain Reaction), which is considered the gold standard diagnostic test for the detection of the SARS-CoV-2 virus. However, the virus continues to evolve with mutations that lead to phenotypic alterations as higher transmissibility, pathogenicity or vaccine evasion. Another big issue are mutations in the annealing sites of primers and probes of RT-PCR diagnostic kits leading to false-negative results. Therefore, here we identify mutations in the N (Nucleocapsid) gene that affects the use of the GeneFinder COVID-19 Plus RealAmp Kit. We sequenced SARS-CoV-2 genomes from 17 positive samples with no N gene detection but with RDRP (RNA-dependent RNA polymerase) and E (Envelope) genes detection, and observed a set of three different mutations affecting the N detection: a deletion of 18 nucleotides (Del28877-28894), a substitution of GGG to AAC (28881-28883) and a frameshift mutation caused by deletion (Del28877-28878). The last one cause a deletion of six AAs (amino acids) located in the central intrinsic disorder region at protein level. We also found this mutation in 99 of the 14,346 sequenced samples by the Sao Paulo state Network for Pandemic Alert of Emerging SARS-CoV-2 variants, demonstrating the circulation of the mutation in Sao Paulo, Brazil. Continuous monitoring and characterization of mutations affecting the annealing sites of primers and probes by genomic surveillance programs are necessary to maintain the effectiveness of the diagnosis of COVID-19.

1 June 2014 in AIDS Research and Human Retroviruses
Verified
Journal Article
Closed access
MPMariana Tomazini Pinto
Mariana Tomazini Pinto
TMTathiane Maistro Malta
Tathiane Maistro Malta
EREvandra Strazza Rodrigues
Evandra Strazza Rodrigues
Daniel Guariz PinheiroDaniel Guariz Pinheiro
Daniel Guariz Pinheiro
RPRodrigo Alexandre Panepucci
Rodrigo Alexandre Panepucci
SKSimone Kashima
Simone Kashima
Human T cell leukemia virus type 1 (HTLV-1) preferentially infects CD4+ T cells and these cells play a central role in HTLV-1 infection. In this study, we investigated the global gene expression profile of circulating CD4+ T cells from the distinct clinical status of HTLV-1-infected individuals in regard to TAX expression levels. CD4+ T cells were isolated from asymptomatic HTLV-1 carrier (HAC) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients in order to identify genes involved in HAM/TSP development using a microarray technique. Hierarchical clustering analysis showed that healthy control (CT) and HTLV-1-infected samples clustered separately. We also observed that the HAC and HAM/TSP groups clustered separately regardless of TAX expression. The gene expression profile of CD4+ T cells was compared among the CT, HAC, and HAM/TSP groups. The paxillin (Pxn), chemokine (C-X-C motif ) receptor 4 (Cxcr4), interleukin 27 (IL27), and granzyme A (Gzma) genes were differentially expressed between the HAC and HAM/TSP groups, regardless of TAX expression. The perforin 1 (Prf1) and forkhead box P3 (Foxp3) genes were increased in the HAM/TSP group and presented a positive correlation to the expression of TAX and the proviral load (PVL). The frequency of CD4+FOXP3+ regulatory T cells (Treg) was higher in HTLV-1-infected individuals. Foxp3 gene expression was positively correlated with cell lysis-related genes (Gzma, Gzmb, and Prf1). These findings suggest that CD4+ T cell activity is distinct between the HAC and HAM/TSP groups.

1 April 2009 in Journal of General Virology
Verified
Journal Article
Open access
SKSimone Kashima
Simone Kashima
EREvandra Strazza Rodrigues
Evandra Strazza Rodrigues
RARochele Azevedo
Rochele Azevedo
ECErick Castelli
Erick Castelli
CMCelso Teixeira Mendes-Junior
Celso Teixeira Mendes-Junior
DCDimas Tadeu Covas
Dimas Tadeu Covas
This study evaluated four polymorphisms located in the DC-SIGN (CD209) gene promoter region (positions −336, −332 −201 and −139) in DNA samples from four Brazilian ethnic groups (Caucasians, Afro-Brazilian, Asians and Amerindians) to establish the population distribution of these single-nucleotide polymorphisms (SNPs) and correlated DC-SIGN polymorphisms and infection in samples from human T-cell lymphotropic virus type 1 (HTLV-1)-infected individuals. To identify CD209 SNPs, 452 bp of the CD209 promoter region were sequenced and the genotype and allelic frequencies were evaluated. This is the first study to show genetic polymorphism in the CD209 gene in distinct Brazilian ethnic groups with the distribution of allelic and genotypic frequency. The results showed that −336A and −139A SNPs were quite common in Asians and that the −201T allele was not observed in Caucasians, Asians or Amerindians. No significant differences were observed between individuals with HTLV-1 disease and asymptomatic patients. However, the −336A variant was more frequent in HTLV-1-infected patients [HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), 80 %; healthy asymptomatic HTLV-1 carriers, 90 %] than in the control group (70 %) [P=0.0197, odds ratio (OR)=2.511, 95 % confidence interval (CI)=1.218–5.179). In addition, the −139A allele was found to be associated with protection against HTLV-1 infection (P=0.0037, OR=0.3758, 95 % CI=0.1954–0.7229) when the HTLV-1-infected patients as a whole were compared with the healthy-control group. These observations suggest that the −139A allele may be associated with HTLV-1 infection, although no significant association was observed among asymptomatic and HAM/TSP patients. In conclusion, the variation observed in SNPs −336 and −139 indicates that this lectin may be of crucial importance in the susceptibility/transmission of HTLV-1 infections.